The official blog of the Lung Institute.

What is My Why? Melissa Rubio

31 Jan 2018
| Under Featured | Posted by
What Is My Why_Melissa

A featured series where Lung Institute employees tell their stories #WhatIsMyWhy

I am the Nurse Practitioner at the Lung Health Institute in Dallas, Texas, and have been with the company since 2015.  I have earned a Ph.D. in Nursing and focus on the collection of research data and patient outcomes.

I was drawn to the Lung Health Institute for various reasons. First, lung health is extremely important to me and second, I am able to see the difference our treatment can make for those with chronic lung disease.

Devoted to the Profession

My previous medical positions involved internal medicine and primary care where I treated chronic lung disease patients with inhalers, steroids and sometimes antibiotics. I witnessed having to tell a patient that there was nothing more we could do to help them. I referred patients for lung-transplant workup and often they were denied because of advanced age, other medical problems or that they were too sick for surgery. Even though I was prescribing treatment, I was witnessing many patients caught in the cycle of exacerbations and hospitalizations.

Family History Motivated Me

While I was growing up, most of the people in my family smoked.  I hated it. Both my grandmother and mother passed away from lung cancer very young and I experienced first-hand the consequences of their smoking.

My doctoral research program has been focused on addiction, including smoking and nicotine addiction. For obvious reasons, lung health is very dear to my heart not only in my personal life but my professional life. The ability to help guide patients through lung wellness using such an innovative and promising treatment as cell therapy is very important to me.

Each and every day I am motivated by the thought that we can offer something that may help people who have not been able to hear hopeful words in a long time.  Finally, there is an alternative to traditional medical treatment of chronic lung disease.

We are the Future of Medicine

I am thrilled to be part of the future of medicine and harnessing the remarkable power of our own cells. I am excited about what we do. For me this is not a job, but a calling.


* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.